355 related articles for article (PubMed ID: 10513555)
1. Effects of the insurmountable angiotensin AT1 receptor antagonist candesartan and the surmountable antagonist losartan on ischemia/reperfusion injury in rat hearts.
Wang QD; Sjöquist PO
Eur J Pharmacol; 1999 Sep; 380(1):13-21. PubMed ID: 10513555
[TBL] [Abstract][Full Text] [Related]
2. Effects of the angiotensin AT1 receptor blocker candesartan on myocardial ischemic/reperfusion injury.
Shimizu M; Sjöquist PO; Wang QD; Rydén L
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S137-42. PubMed ID: 9892154
[TBL] [Abstract][Full Text] [Related]
3. The angiotensin II AT1-receptor antagonist candesartan improves functional recovery and reduces the no-reflow area in reperfused ischemic rat hearts.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Jul; 34(1):78-81. PubMed ID: 10413071
[TBL] [Abstract][Full Text] [Related]
4. Combination of a calcium antagonist, a lipid-peroxidation inhibitor, and an angiotensin AT1-receptor antagonist provides additive myocardial infarct size-limiting effect in pigs.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1999 Oct; 34(4):512-7. PubMed ID: 10511125
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1998 Aug; 32(2):231-8. PubMed ID: 9700985
[TBL] [Abstract][Full Text] [Related]
6. Critical role of AT1 receptor expression after ischemia/reperfusion in isolated rat hearts: beneficial effect of antisense oligodeoxynucleotides directed at AT1 receptor mRNA.
Yang BC; Phillips MI; Zhang YC; Kimura B; Shen LP; Mehta P; Mehta JL
Circ Res; 1998 Sep; 83(5):552-9. PubMed ID: 9734478
[TBL] [Abstract][Full Text] [Related]
7. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts.
Ford WR; Clanachan AS; Jugdutt BI
Circulation; 1996 Dec; 94(12):3087-9. PubMed ID: 8989113
[TBL] [Abstract][Full Text] [Related]
8. Bradykinin-dependent cardioprotective effects of losartan against ischemia and reperfusion in rat hearts.
Zhu P; Zaugg CE; Hornstein PS; Allegrini PR; Buser PT
J Cardiovasc Pharmacol; 1999 May; 33(5):785-90. PubMed ID: 10226867
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic differences of various AT1-receptor blockers in isolated vessels of different origin.
Morsing P; Adler G; Brandt-Eliasson U; Karp L; Ohlson K; Renberg L; Sjöquist PO; Abrahamsson T
Hypertension; 1999 Jun; 33(6):1406-13. PubMed ID: 10373224
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin II AT1 receptor antagonist candesartan at antihypertensive plasma concentrations reduces damage induced by ischemia-reperfusion.
Shimizu M; Wang QD; Sjöquist PO; Rydén L
Cardiovasc Drugs Ther; 1999 Jul; 13(4):347-53. PubMed ID: 10516871
[TBL] [Abstract][Full Text] [Related]
12. Effects of the angiotensin II subtype 1 receptor antagonist losartan on functional recovery of isolated rat hearts undergoing global myocardial ischemia-reperfusion.
Flynn JD; Akers WS
Pharmacotherapy; 2003 Nov; 23(11):1401-10. PubMed ID: 14620386
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S101-3. PubMed ID: 9892149
[TBL] [Abstract][Full Text] [Related]
14. An angiotensin II type 1 receptor blocker, candesartan, increases myocardial apoptosis in rats with acute ischemia-reperfusion.
Chen M; Hamada M; Hiasa G; Suzuki M; Ikeda S; Hiwada K
Hypertens Res; 2001 May; 24(3):323-9. PubMed ID: 11409658
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotection with angiotensin converting enzyme inhibitor and angiotensin II type 1 receptor antagonist is not abolished by nitric oxide synthase inhibitor in ischemia-reperfused rabbit hearts.
Kawabata H; Ryomoto T; Ishikawa K
Hypertens Res; 2001 Jul; 24(4):403-9. PubMed ID: 11510753
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II subtype 1 (AT1) receptors contribute to ischemic contracture and regulate chemomechanical energy transduction in isolated transgenic rat (alphaMHC-hAT1)594-17 hearts.
Han H; Hoffmann S; Hu K; Ertl G
Eur J Heart Fail; 2002 Mar; 4(2):131-7. PubMed ID: 11959040
[TBL] [Abstract][Full Text] [Related]
17. Intermittent losartan administration triggers cardiac post-conditioning in isolated rat hearts: role of BK2 receptors.
Sgarra L; Leo V; Addabbo F; Iacobazzi D; Carratù MR; Montagnani M; Potenza MA
PLoS One; 2014; 9(2):e88542. PubMed ID: 24520397
[TBL] [Abstract][Full Text] [Related]
18. Role of cardiac ATP-sensitive K+ channels induced by angiotensin II type 1 receptor antagonist on metabolism, contraction and relaxation in ischemia-reperfused rabbit heart.
Kawabata H; Ryomoto T; Ishikawa K
Jpn Circ J; 2001 May; 65(5):451-6. PubMed ID: 11348052
[TBL] [Abstract][Full Text] [Related]
19. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
[TBL] [Abstract][Full Text] [Related]
20. Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
Wagenaar LJ; Voors AA; Buikema H; van Buiten A; Lübeck RH; Boonstra PW; van Veldhuisen DJ; van Gilst WH
Cardiovasc Drugs Ther; 2002 Jul; 16(4):311-6. PubMed ID: 12652100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
